- New
-
Topics
- All Categories
- Metaphysics and Epistemology
- Value Theory
- Science, Logic, and Mathematics
- Science, Logic, and Mathematics
- Logic and Philosophy of Logic
- Philosophy of Biology
- Philosophy of Cognitive Science
- Philosophy of Computing and Information
- Philosophy of Mathematics
- Philosophy of Physical Science
- Philosophy of Social Science
- Philosophy of Probability
- General Philosophy of Science
- Philosophy of Science, Misc
- History of Western Philosophy
- Philosophical Traditions
- Philosophy, Misc
- Other Academic Areas
- Journals
- Submit material
- More
Expectations regarding cognitive enhancement create substantial challenges
Journal of Medical Ethics 35 (8):469-470 (2009)
Abstract
A recent discussion on cognitive enhancers has caused some controversy in the ethics and neuroscience fields by coming out in favour of making neuropharmaceuticals with enhancing properties available for general consumption. We highlight in this brief commentary why concerns regarding efficacy and safety, demands on resources, and public health are substantive enough to warrant serious reconsideration before pharmaceutical performance enhancement can be widely supportedAuthor's Profile
Links
PhilArchive
External links
(no proxy)
Setup an account with your affiliations in order to access resources via your University's proxy server
Through your library
- Sign in / register and customize your OpenURL resolver
- Configure custom resolver
My notes
Similar books and articles
Cognitive Enhancement: Methods, Ethics, Regulatory Challenges. [REVIEW]Nick Bostrom - 2009 - Science and Engineering Ethics 15 (3):311-341.
Cognitive enhancement, lifestyle choice or misuse of prescription drugs?Eric Racine & Cynthia Forlini - 2008 - Neuroethics 3 (1):1-4.
Australian University Students' Attitudes Towards the Acceptability and Regulation of Pharmaceuticals to Improve Academic Performance.Stephanie Bell, Brad Partridge, Jayne Lucke & Wayne Hall - 2012 - Neuroethics 6 (1):197-205.
Genetic enhancement: Plan now to act later.Maxwell J. Mehlman - 2005 - Kennedy Institute of Ethics Journal 15 (1):77-82.
An aristotelian approach to cognitive enhancement.Lubomira Radoilska - 2010 - Journal of Value Inquiry 44 (3):365–375.
Developing Public Health Approaches to Cognitive Enhancement: An Analysis of Current Reports.S. M. Outram & E. Racine - 2011 - Public Health Ethics 4 (1):93-105.
Getting moral enhancement right: The desirability of moral bioenhancement.Ingmar Persson & Julian Savulescu - 2011 - Bioethics 27 (3):124-131.
Neuroethics of Cognitive Enhancement.Danielle C. Turner & Barbara J. Sahakian - 2006 - Biosocieties 1 (1):113--123.
Cognitive disability in a society of equals.Jonathan Wolff - 2009 - Metaphilosophy 40 (3-4):402-415.
The perils of cognitive enhancement and the urgent imperative to enhance the moral character of humanity.Ingmar Persson & Julian Savulescu - 2008 - Journal of Applied Philosophy 25 (3):162-177.
Reining In the Pharmacological Enhancement Train: We Should Remain Vigilant about Regulatory Standards for Prescribing Controlled Substances.Katherine Drabiak-Syed - 2011 - Journal of Law, Medicine and Ethics 39 (2):272-279.
Which Came First, the Chicken or the Egg? Rethinking Causal Directions between Neural Mechanisms, Agency, and Human Enhancement.Carissa Véliz - 2011 - American Journal of Bioethics Neuroscience 2 (3):46-48.
Analytics
Added to PP
2010-09-13
Downloads
41 (#369,691)
6 months
6 (#431,022)
2010-09-13
Downloads
41 (#369,691)
6 months
6 (#431,022)
Historical graph of downloads
Author's Profile
Citations of this work
Deflating the Neuroenhancement Bubble.Jayne C. Lucke, Stephanie Bell, Brad Partridge & Wayne D. Hall - 2011 - American Journal of Bioethics Neuroscience 2 (4):38-43.
tDCS for Memory Enhancement: Analysis of the Speculative Aspects of Ethical Issues.Nathalie Voarino, Veljko Dubljević & Eric Racine - 2017 - Frontiers in Human Neuroscience 10.
Autonomy and the Unintended Legal Consequences of Emerging Neurotherapies.Jennifer A. Chandler - 2011 - Neuroethics 6 (2):249-263.
Generating genius: how an Alzheimer’s drug became considered a ‘cognitive enhancer’ for healthy individuals.Lucie Wade, Cynthia Forlini & Eric Racine - 2014 - BMC Medical Ethics 15 (1):37.
Reining in the Pharmacological Enhancement Train: We Should Remain Vigilant about Regulatory Standards for Prescribing Controlled Substances.Katherine Drabiak-Syed - 2011 - Journal of Law, Medicine and Ethics 39 (2):272-279.
References found in this work
Towards responsible use of cognitive-enhancing drugs by the healthy.Henry Greely, Barbara Sahakian, John Harris, Ronald Kessler, Gazzaniga C., Campbell Michael, Farah Philip & J. Martha - 2008 - Nature 456:702-705.
PhilPapers logo by Andrea Andrews and Meghan Driscoll.
This site uses cookies and Google Analytics (see our terms & conditions for details regarding the privacy implications). Use of this site is subject to terms & conditions.
All rights reserved by The PhilPapers Foundation
Server: philpapers-web-7c76586df8-pp8v9 uwo